Paolo Durigutto
Trieste, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
PLGA/PVA nanoparticles to deliver a protein-based cancer vaccine targeting GPC1 for the treatment of pancreatic ductal adenocarcinoma.
Journal: Nanomedicine (London, England)
Published: May 25, 2026
Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinoma.
Journal: Nanomedicine (London, England)
Published: January 15, 2025
β2GPI-targeted polymeric nanoparticles form a protective layer to prevent vascular thrombosis in an anti-phospholipid syndrome model.
Journal: Frontiers in immunology
Published: October 31, 2024
A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma.
Journal: Journal of translational medicine
Published: October 06, 2023
Plasminogen activator-coated nanobubbles targeting cellbound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategy.
Journal: Haematologica
Published: June 08, 2022
Multiple-Organ Complement Deposition on Vascular Endothelium in COVID-19 Patients.
Journal: Biomedicines
Published: June 29, 2021
Multi-organ complement deposition in COVID-19 patients.
Journal: medRxiv : the preprint server for health sciences
Published: January 14, 2021
Complement Activation and Thrombin Generation by MBL Bound to β2-Glycoprotein I.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: May 15, 2020
Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis.
Journal: Journal of autoimmunity
Published: February 21, 2019
Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases?
Journal: Nature reviews. Rheumatology
Published: June 13, 2018
Last Updated: 09/26/2026